Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2004

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to              .

 

Commission file number 000-23783

 


 

MICROMUSE INC.

(Exact name of registrant as specified in its charter)

 


 

DELAWARE   94-3288385

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

139 TOWNSEND STREET

SAN FRANCISCO, CALIFORNIA 94107

(415) 538-9090

(Address, including ZIP code, and telephone number)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

79,480,766 shares of Common Stock, $0.01 par value, were outstanding as of July 31, 2004

 



Table of Contents

MICROMUSE INC.

 

TABLE OF CONTENTS

 

        Page

Explanatory Note

   

PART I - Financial Information

   

Item 1.

 

Condensed Consolidated Financial Statements (Unaudited):

   
   

Condensed Consolidated Balance Sheets as of June 30, 2004 and September 30, 2003

  4
   

Condensed Consolidated Statements of Operations for the three and nine months ended June 30, 2004 and 2003*

  5
   

Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2004 and 2003*

  6
   

Notes to Condensed Consolidated Financial Statements

  7
   

*  The Condensed Consolidated Statement of Operations for the three and nine months ended June 30, 2003 and the Condensed Consolidated Statement of Cash Flows for the nine months ended June 30, 2003 have been restated as described in Note 2 of Notes to Condensed Consolidated Financial Statements.

   

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  12

Item 3.

 

Quantitative and Qualitative Disclosures about Market Risk

  24

Item 4.

 

Controls and Procedures

  25

PART II - Other Information

   

Item 1.

 

Legal Proceedings

  26

Item 2.

 

Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

  26

Item 3.

 

Defaults upon Senior Securities

  26

Item 4.

 

Submission of Matters to a Vote of Security Holders

  26

Item 5.

 

Other Information

  27

Item 6.

 

Exhibits and Reports on Form 8-K

  28

Signatures

  29

 

2


Table of Contents

EXPLANATORY NOTE

 

This Form 10-Q includes restated financial information for certain periods indicated below that ended prior to our fiscal year that began on October 1, 2003.

 

The Company has restated its consolidated financial statements for the fiscal years ended September 30, 2001 and 2002 and for the quarters ended December 31, 2000 through June 30, 2003. Accordingly, the financial statements for those periods described above that have been included in the Company’s previous filings with the Securities and Exchange Commission in 2003 or earlier or included in previous announcements in 2003 or earlier should not be relied upon.

 

The Company’s Form 10-K for the fiscal year ended September 30, 2003, filed with the SEC on May 17, 2004, contains restated information for all of the above periods to which the restatement applies and other information relating to the restatement, in the Form 10-K Item 6 “Selected Financial Data,” Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Restatement of Financial Statements,” Notes 2 and 11 of the Notes to Consolidated Financial Statements included in Item 8, and Item 9A, “Controls and Procedures.”

 

Certain information concerning the restatement relating to the periods included in this report is contained in Part I to this Form 10-Q in Item 1, Note 2 below to the Condensed Consolidated Financial Statements (Unaudited), Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Item 4, “Controls and Procedures.” This information should be read in conjunction with relevant information in the Company’s most recent Form 10-K referred to above.

 

3


Table of Contents

PART I - FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements

 

MICROMUSE INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

 

    

June 30,

2004

(Unaudited)


   

September 30,
2003 *

 


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 101,432     $ 89,385  

Short-term investments

     15,168       33,196  

Accounts receivable, net

     25,990       13,439  

Prepaid expenses and other current assets

     9,402       6,269  
    


 


Total current assets

     151,992       142,289  

Property and equipment, net

     5,966       5,976  

Long-term investments

     74,864       67,529  

Goodwill, net

     50,929       49,032  

Other intangible assets, net

     8,220       12,861  
    


 


     $ 291,971     $ 277,687  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 5,741     $ 6,849  

Accrued expenses

     11,082       9,855  

Accrued payroll

     12,330       10,532  

Income taxes payable

     6,328       6,368  

Deferred revenue

     46,855       37,567  
    


 


Total current liabilities

     82,336       71,171  

Deferred revenue, less current portion

     2,261       2,760  
    


 


Total liabilities

     84,597       73,931  

Stockholders’ equity:

                

Preferred stock; $0.01 par value; 5,000 shares authorized; no shares issued and outstanding

     —         —    

Common stock; $0.01 par value; 200,000 shares authorized; 79,517 and 78,544 shares outstanding as of June 30, 2004 and September 30, 2003, respectively

     795       785  

Additional paid-in capital

     214,873       210,697  

Treasury stock

     (2,657 )     (2,657 )

Accumulated other comprehensive loss

     (1,577 )     (1,548 )

Accumulated deficit

     (4,060 )     (3,521 )
    


 


Total stockholders’ equity

     207,374       203,756  
    


 


     $ 291,971     $ 277,687  
    


 



* September 30, 2003 balances are derived from the audited financial statements included in the Company’s 2003 Annual Report on Form 10-K.

 

See accompanying notes to the condensed consolidated financial statements

 

4


Table of Contents

MICROMUSE INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

     Three months ended
June 30,


   

Nine months ended

June 30,


 
     2004

    2003

    2004

    2003

 
           (As Restated)           (As Restated)  

Revenues:

                                

License

   $ 17,690     $ 18,233     $ 58,297     $ 50,390  

Maintenance and services

     17,135       14,692       52,002       42,054  
    


 


 


 


Total revenues

     34,825       32,925       110,299       92,444  
    


 


 


 


Cost of revenues:

                                

License

     1,468       1,251       4,355       3,335  

Maintenance and services

     3,140       2,593       8,456       8,115  

Amortization of developed technology

     1,527       1,053       4,515       3,089  
    


 


 


 


Total cost of revenues

     6,135       4,897       17,326       14,539  
    


 


 


 


Gross profit

     28,690       28,028       92,973       77,905  
    


 


 


 


Operating expenses:

                                

Sales and marketing

     15,696       14,436       47,181       45,833  

Research and development

     8,102       7,417       24,121       21,726  

General and administrative

     6,684       3,947       18,528       12,623  

Restatement costs

     1,616       —         5,466       —    

Amortization of other intangible assets

     48       194       143       1,115  

Restructuring costs

     —         1,655       —         4,795  
    


 


 


 


Total operating expenses

     32,146       27,649       95,439       86,092  
    


 


 


 


Income (loss) from operations

     (3,456 )     379       (2,466 )     (8,187 )

Other income, net

     1,151       693       2,865       3,378  
    


 


 


 


Income (loss) before income taxes

     (2,305 )     1,072       399       (4,809 )

Income tax provision (benefit)

     181       (144 )     938       899  
    


 


 


 


Net income (loss)

   $ (2,486 )   $ 1,216     $ (539 )   $ (5,708 )
    


 


 


 


Per share data:

                                

Basic net income (loss)

   $ (0.03 )   $ 0.02     $ (0.01 )   $ (0.07 )

Diluted net income (loss)

   $ (0.03 )   $ 0.02     $ (0.01 )   $ (0.07 )

Weighted average shares used in computing:

                                

Basic net income (loss) per share

     78,993       76,635       78,760       76,577  

Diluted net income (loss) per share

     78,993       80,087       78,760       76,577  

 

See accompanying notes to the condensed consolidated financial statements

 

5


Table of Contents

MICROMUSE INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

    

Nine months ended

June 30,


 
     2004

    2003

 
           (As Restated)  

Cash flows from operating activities:

                

Net loss

   $ (539 )   $ (5,708 )

Adjustments to reconcile net loss to net cash provided by operating activities:

                

Depreciation and amortization

     7,576       9,178  

Purchased in process research & development

     —         142  

Non-cash stock based compensation

     553       54  

Tax benefit related to exercise of stock options

     464       427  

Changes in assets and liabilities, net of acquired amounts:

                

Accounts receivable, net

     (12,551 )     11,088  

Prepaid expenses and other current assets

     (3,133 )     (736 )

Accounts payable

     (1,108 )     1,803  

Accrued expenses

     3,025       (3,714 )

Income taxes payable

     (40 )     (479 )

Deferred revenue

     8,789       9,470  
    


 


Net cash provided by operating activities

     3,036       21,525  
    


 


Cash flows from investing activities:

                

Capital expenditures

     (2,862 )     (836 )

Investment purchases

     (165,980 )     (130,252 )

Investment sales

     176,672       77,370